ID   OAS1A_RAT               Reviewed;         358 AA.
AC   Q05961;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   08-NOV-2023, entry version 134.
DE   RecName: Full=2'-5'-oligoadenylate synthase 1A;
DE            Short=(2-5')oligo(A) synthase 1A;
DE            Short=2-5A synthase 1A;
DE            EC=2.7.7.84 {ECO:0000250|UniProtKB:P11928};
GN   Name=Oas1a; Synonyms=Oas1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7764002; DOI=10.1038/nbt0993-1048;
RA   Truve E., Aaspollu A., Honkanen J., Puska R., Mehto M., Hassi A.,
RA   Teeri T.H., Kelve M., Seppanen P., Saarma M.;
RT   "Transgenic potato plants expressing mammalian 2'-5' oligoadenylate
RT   synthetase are protected from potato virus X infection under field
RT   conditions.";
RL   Biotechnology (N.Y.) 11:1048-1052(1993).
RN   [2]
RP   REVIEW.
RX   PubMed=17024523; DOI=10.1007/s00239-006-0073-3;
RA   Perelygin A.A., Zharkikh A.A., Scherbik S.V., Brinton M.A.;
RT   "The mammalian 2'-5' oligoadenylate synthetase gene family: evidence for
RT   concerted evolution of paralogous Oas1 genes in Rodentia and
RT   Artiodactyla.";
RL   J. Mol. Evol. 63:562-576(2006).
CC   -!- FUNCTION: Interferon-induced, dsRNA-activated antiviral enzyme which
CC       plays a critical role in cellular innate antiviral response. In
CC       addition, it may also play a role in other cellular processes such as
CC       apoptosis, cell growth, differentiation and gene regulation.
CC       Synthesizes higher oligomers of 2'-5'-oligoadenylates (2-5A) from ATP
CC       which then bind to the inactive monomeric form of ribonuclease L (RNase
CC       L) leading to its dimerization and subsequent activation. Activation of
CC       RNase L leads to degradation of cellular as well as viral RNA,
CC       resulting in the inhibition of protein synthesis, thus terminating
CC       viral replication. Can mediate the antiviral effect via the classical
CC       RNase L-dependent pathway or an alternative antiviral pathway
CC       independent of RNase L. {ECO:0000250|UniProtKB:P00973}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3 ATP = 5'-triphosphoadenylyl-(2'->5')-adenylyl-(2'->5')-
CC         adenosine + 2 diphosphate; Xref=Rhea:RHEA:34407, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:67143; EC=2.7.7.84;
CC         Evidence={ECO:0000250|UniProtKB:P11928};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P00973};
CC   -!- ACTIVITY REGULATION: Produced as a latent enzyme which is activated by
CC       dsRNA generated during the course of viral infection. The dsRNA
CC       activator must be at least 15 nucleotides long, and no modification of
CC       the 2'-hydroxyl group is tolerated. ssRNA or dsDNA do not act as
CC       activators. {ECO:0000250|UniProtKB:P00973}.
CC   -!- SUBUNIT: Monomer. Homotetramer. Interacts with OAS1D.
CC       {ECO:0000250|UniProtKB:P00973, ECO:0000250|UniProtKB:P11928,
CC       ECO:0000303|PubMed:17024523}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P11928}.
CC       Mitochondrion {ECO:0000250|UniProtKB:P00973}. Nucleus
CC       {ECO:0000250|UniProtKB:P00973}. Microsome
CC       {ECO:0000250|UniProtKB:P00973}. Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P00973}. Note=Associated with different
CC       subcellular fractions such as mitochondrial, nuclear, and rough/smooth
CC       microsomal fractions. {ECO:0000250|UniProtKB:P00973}.
CC   -!- SIMILARITY: Belongs to the 2-5A synthase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z18877; CAA79317.1; -; mRNA.
DR   PIR; S31407; S31407.
DR   RefSeq; NP_620268.1; NM_138913.1.
DR   AlphaFoldDB; Q05961; -.
DR   SMR; Q05961; -.
DR   STRING; 10116.ENSRNOP00000036734; -.
DR   iPTMnet; Q05961; -.
DR   PhosphoSitePlus; Q05961; -.
DR   PaxDb; 10116-ENSRNOP00000036734; -.
DR   GeneID; 192281; -.
DR   KEGG; rno:192281; -.
DR   UCSC; RGD:621760; rat.
DR   AGR; RGD:621760; -.
DR   CTD; 246730; -.
DR   RGD; 621760; Oas1a.
DR   eggNOG; KOG0001; Eukaryota.
DR   InParanoid; Q05961; -.
DR   OrthoDB; 4638494at2759; -.
DR   BRENDA; 2.7.7.84; 5301.
DR   PRO; PR:Q05961; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0001730; F:2'-5'-oligoadenylate synthetase activity; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003725; F:double-stranded RNA binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0035458; P:cellular response to interferon-beta; ISO:RGD.
DR   GO; GO:0051607; P:defense response to virus; IBA:GO_Central.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0006006; P:glucose metabolic process; ISO:RGD.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0070106; P:interleukin-27-mediated signaling pathway; ISO:RGD.
DR   GO; GO:2000342; P:negative regulation of chemokine (C-X-C motif) ligand 2 production; ISO:RGD.
DR   GO; GO:0071659; P:negative regulation of IP-10 production; ISO:RGD.
DR   GO; GO:0060339; P:negative regulation of type I interferon-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0045071; P:negative regulation of viral genome replication; ISO:RGD.
DR   GO; GO:0032728; P:positive regulation of interferon-beta production; ISO:RGD.
DR   GO; GO:0071639; P:positive regulation of monocyte chemotactic protein-1 production; ISO:RGD.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0009615; P:response to virus; ISO:RGD.
DR   GO; GO:0043129; P:surfactant homeostasis; ISO:RGD.
DR   GO; GO:0034138; P:toll-like receptor 3 signaling pathway; ISO:RGD.
DR   GO; GO:0034142; P:toll-like receptor 4 signaling pathway; ISO:RGD.
DR   CDD; cd05400; NT_2-5OAS_ClassI-CCAase; 1.
DR   Gene3D; 1.10.1410.20; 2'-5'-oligoadenylate synthetase 1, domain 2; 1.
DR   Gene3D; 3.30.460.10; Beta Polymerase, domain 2; 1.
DR   InterPro; IPR018952; 2-5-oligoAdlate_synth_1_dom2/C.
DR   InterPro; IPR006117; 2-5OAS_C_CS.
DR   InterPro; IPR043518; 2-5OAS_N_CS.
DR   InterPro; IPR006116; NT_2-5OAS_ClassI-CCAase.
DR   InterPro; IPR043519; NT_sf.
DR   InterPro; IPR002934; Polymerase_NTP_transf_dom.
DR   PANTHER; PTHR11258:SF13; 2'-5'-OLIGOADENYLATE SYNTHASE 1; 1.
DR   PANTHER; PTHR11258; 2-5 OLIGOADENYLATE SYNTHETASE; 1.
DR   Pfam; PF01909; NTP_transf_2; 1.
DR   Pfam; PF10421; OAS1_C; 1.
DR   SUPFAM; SSF81301; Nucleotidyltransferase; 1.
DR   SUPFAM; SSF81631; PAP/OAS1 substrate-binding domain; 1.
DR   PROSITE; PS00832; 25A_SYNTH_1; 1.
DR   PROSITE; PS00833; 25A_SYNTH_2; 1.
DR   PROSITE; PS50152; 25A_SYNTH_3; 1.
PE   2: Evidence at transcript level;
KW   Antiviral defense; ATP-binding; Cytoplasm; Endoplasmic reticulum; Immunity;
KW   Innate immunity; Magnesium; Metal-binding; Microsome; Mitochondrion;
KW   Nucleotide-binding; Nucleotidyltransferase; Nucleus; Reference proteome;
KW   RNA-binding; Transferase.
FT   CHAIN           1..358
FT                   /note="2'-5'-oligoadenylate synthase 1A"
FT                   /id="PRO_0000160263"
FT   REGION          14..61
FT                   /note="Interaction with dsRNA"
FT                   /evidence="ECO:0000250|UniProtKB:P00973"
FT   REGION          201..211
FT                   /note="Interaction with dsRNA"
FT                   /evidence="ECO:0000250|UniProtKB:P00973"
FT   BINDING         64
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P00973"
FT   BINDING         76
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P00973"
FT   BINDING         78
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P00973"
FT   BINDING         149
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P00973"
FT   BINDING         211
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P29728"
FT   BINDING         214
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P00973"
FT   BINDING         231
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P00973"
SQ   SEQUENCE   358 AA;  41666 MW;  AE0F24E6A5D45BEA CRC64;
     MEQELRSTPS WKLDKFIEVY LLPNTSFRDD VKSAINVLCD FLKERCFRDT VHPVRVSKVV
     KGGSSGKGTT LKGKSDADLV VFLNNFTSFE DQLNRRGEFI KEIKKQLYEV QREKHFRVKF
     EVQSSWWPNP RALSFKLSAP HLQQEVEFDV LPAYDVLGHV SLYSNPDPKI YTILISECIS
     LGKDGEFSTC FTELQRNFLK QRPTKLKSLI RLVKHWYQLC KEKLGKPLPP QYALELLTVY
     AWERGNGITE FNTAQGFRTI LELVTKYQQL RIYWTKYYDF QHPDVSKYLH RQLRKSRPVI
     LDPADPTGNV AGGNQEGWRR LASEARLWLQ YPCFMNRGGS PVSSWEVPVD EAWSCILL
//
